Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic elongation factor 1A2 (eEF1A2) is a protein that plays a crucial role in protein synthesis by delivering aminoacyl-tRNAs to the ribosome. It is highly expressed in brain, heart, and skeletal muscle. Beyond translation, eEF1A2 is involved in actin cytoskeleton remodeling and filopodia formation. It is overexpressed in several cancers, making it a potential therapeutic target. Plitidepsin is a drug that targets eEF1A2.
Binds to eEF1A2, leading to oxidative stress and activation of JNK/p38 MAPK pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic Elongation Factor 1A2 (eEF1A2).